Evidence map›Paper›PMID 31215094›Full record

ArticleCancer science2019

Roles of the hexosamine biosynthetic pathway and pentose phosphate pathway in bile acid-induced cancer development.

Masayoshi Munemoto, Ken-Ichi Mukaisho, Tomoharu Miyashita, Katsunobu Oyama, Yusuke Haba, Koichi Okamoto, Jun Kinoshita, Itasu Ninomiya, Sachio Fushida, Naoko Taniura and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cancer science, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Cancer metabolism and carcinogenesis.Experimental hematology & oncology · 2024
    Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Cells · 2022
    Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Masayoshi MunemotoDepartment of Gastroenterological Surgery, Kanazawa University Hospital, Kanazawa, Japan.
Ken-Ichi MukaishoDivision of Molecular and Diagnostic Pathology, Department of Pathology, Shiga University of Medical Science, Otsu, Japan.ORCID https://orcid.org/0000-0002-0488-0100
Tomoharu MiyashitaDepartment of Gastroenterological Surgery, Kanazawa University Hospital, Kanazawa, Japan.
Katsunobu OyamaDepartment of Surgery, Public Central Hospital of Matto Ishikawa, Hakusan, Japan.
Yusuke HabaDepartment of Gastroenterological Surgery, Kanazawa University Hospital, Kanazawa, Japan.
Koichi OkamotoDepartment of Gastroenterological Surgery, Kanazawa University Hospital, Kanazawa, Japan.
Jun KinoshitaDepartment of Gastroenterological Surgery, Kanazawa University Hospital, Kanazawa, Japan.
Itasu NinomiyaDepartment of Gastroenterological Surgery, Kanazawa University Hospital, Kanazawa, Japan.
Sachio FushidaDepartment of Gastroenterological Surgery, Kanazawa University Hospital, Kanazawa, Japan.ORCID https://orcid.org/0000-0001-5567-7383
Naoko TaniuraDivision of Molecular and Diagnostic Pathology, Department of Pathology, Shiga University of Medical Science, Otsu, Japan.
Hiroyuki SugiharaDivision of Molecular and Diagnostic Pathology, Department of Pathology, Shiga University of Medical Science, Otsu, Japan.
Takashi FujimuraDepartment of Surgery, Toyama City Hospital, Toyama, Japan.
Kanazawa University Hospital · JPShiga University of Medical Science · JPPublic Central Hospital of Matto Ishikawa · JPToyama City Hospital · JP

Funding

AMED 18ck0106264h0002Astra Zeneca under AZKK Research 201500078
6 · The paper itself

Abstract

Esophageal squamous cell carcinomas (ESCCs) as well as adenocarcinomas (EACs) were developed in rat duodenal contents reflux models (reflux model). The present study aimed to shed light on the mechanism by which bile acid stimulation causes cancer onset and progression. Metabolomics analyses were performed on samples of neoplastic and nonneoplastic tissues from reflux models, and K14D, cultivated from a nonmetastatic, primary ESCC, and ESCC-DR, established from a metastatic thoracic lesion. ESCC-DRtca2M was prepared by treating ESCC-DR cells with taurocholic acid (TCA) to accelerate cancer progression. The lines were subjected to comprehensive genomic analyses. In addition, protein expression levels of glucose-6-phosphate dehydrogenase (G6PD), nuclear factor kappa B (NF-κB) (p65) and O-linked N-Acetylglucosamine (O-GlcNAc) were compared among lines. Cancers developed in the reflux models exhibited greater hexosamine biosynthesis pathway (HBP) activation compared with the nonneoplastic tissues. Expression of O-GlcNAc transferase (OGT) increased considerably in both ESCC and EAC compared with nonneoplastic squamous epithelium. Conversely, cell line-based experiments revealed the greater activation of the pentose phosphate pathway (PPP) at higher degrees of malignancy. G6PD overexpression in response to TCA exposure was observed. Both NF-κB (p65) and O-GlcNAc were expressed more highly in ESCC-DRtca2M than in the other cell lines. Moreover, ESCC-DRtca2M cells had additional chromosomal abnormalities in excess of ESCC-DR cells. Overall, glucose metabolism was upregulated in both esophageal cancer tissue and cell lines. While bile acids are not mutagenic, chronic exposure seems to trigger NF-κB(p65) activation, potentially inducing genetic mutations as well as facilitating carcinogenesis and cancer progression. Glucose metabolism was upregulated in both esophageal cancer tissue and cell lines, and the HBP was activated in the former. The cell line-based experiments demonstrated upregulation of the pentose phosphate pathway (PPP) at higher degrees of malignancy. While bile acids are not mutagenic, chronic exposure seems to trigger G6PD overexpression and NF-κB (p65) activation, potentially inducing genetic mutations as well as facilitating carcinogenesis and cancer progression.

Indexed as

AcetylglucosamineAdenocarcinomaAnimalsBile Acids and SaltsBiosynthetic PathwaysCell Line, TumorEsophageal NeoplasmsEsophageal Squamous Cell CarcinomaGene Expression Regulation, NeoplasticGlucoseGlucosephosphate DehydrogenaseHexosaminesLysineMaleNF-kappa BPentose Phosphate Pathway2-epsilon-lysino-2-deoxy-6-phosphoglucoseAcetylglucosamineBile Acids and SaltsGlucoseGlucosephosphate DehydrogenaseHexosaminesLysineNF-kappa Bbile acidshexosamine biosynthesis pathwaymetabolomics analysesNF-κBpentose phosphate pathway

Identifiers

PMID31215094
PMCPMC6676276
OpenAlexW2952484688

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.